Skip to main content
. 2015 Apr 9;48(1):304–311. doi: 10.4143/crt.2014.339

Fig. 2.

Fig. 2.

Kaplan-Meier plots of progression-free survival (A) and overall survival (B) of young patients, elderly patients with dose intensity of doxorubicin (DID) ≤ 10 mg/m2/wk, and elderly patients with DID > 10 mg/m2/wk.